Negative regulation of T-cell activation and autoimmunity by Mgat5 N-glycosylation
By M. Demetriou, M. Granovsky, S. Quaggin, J. Dennis. Nature, 2001
903 citations recorded by the source corpus.
Subfields: Immunology, Molecular Biology
View Paper: https://www.semanticscholar.org/paper/060687905f7e68971a8a03cae423691569dd7f7f
How researchers see this paper
The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.
In Immunology
In Molecular Biology
Citations in the corpus
- T-cell-antigen recognition and the immunological synapse (2003, background): “An important regulatory role for N -glycan synthesis in T-cell activation has recently been shown by Dennis and colleague”
- Protein-glycan interactions in the control of innate and adaptive immune responses (2008, background): “Notably, multivalent galectin-3–N-glycan lattices can limit TCR clustering at sites of immunological synapse and increase agonist threshold for TCR signaling, and thus they may contribute to T cell homeostasi”
- Immunosuppressive strategies that are mediated by tumor cells. (2007, background): “In addition, Demetriou and colleagues found that multivalent complexes composed of galectin-3 and specific N-glycans may restrict the lateral mobility of TCR complexes and restrain TCR-mediated signal transduction (139).”
- Human Decidual Natural Killer Cells Are a Unique NK Cell Subset with Immunomodulatory Potential (2003, background): “Galectin binding restricts TCR recruitment to the synapse by formation of a lattice resulting from its binding to tetraantennary N-glycosylated glycoproteins (58).”
- Mammalian glycosylation in immunity (2008, neutral): “GnT5-deficient mice have increased delayed-type hypersensitivity responses, increased susceptibility to experimental autoimmune encephalomyelitis (EAE) and increased glomerulonephritis that is associated with immune-complex depositio”
- Biological roles of glycans (2016, background): “The N-linked glycans on cell surface glycoproteins can have varying degrees of branching (597), and glycan branching is specifically upregulated in T cell activation (598), and in malignant transformation (599–604).”
- Glycosylation in cellular mechanisms of health and disease. (2006, background): “Loss of the GlcNAcT-V glycosyltransferase, for example, was found to induce coclustering of T cell receptors at the cell surface, reducing the threshold for immune activation and causing autoimmune disease (Demetriou et al., 2001).”
- Galectins as modulators of tumour progression (2005, background): “and can restrict T-cell receptor (TCR)-initiated signal transduction by forming multivalent complexes with glycans present on the TC”
- Galectin-3: an open-ended story. (2006, background): “Interestingly, mice deficient in Mgat5 show enhanced delaytype hypersensitivity and increased susceptibility to autoimmune disorders [51].”
- Turning 'sweet' on immunity: galectin–glycan interactions in immune tolerance and inflammation (2009, background): “Elegant work has shown that multivalent galectin 3–N-glycan complexes can limit TCR clustering by restricting lateral TCR movement within the plane of the membrane, thereby increasing agonist threshold for TCR signallin”
- Complex N-glycan number and degree of branching cooperate to regulate cell proliferation and differentiation. (2007, background): “Thus, Mgat5 / cells display reduced galectin-3 binding to complex N-glycans on the T cell receptor (TCR; Demetriou et al., 2001) as well as EGF receptor (EGFR) and TbRII in epithelial cells (Partridge et al., 2004).”